TrialThe oncologist2020

Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer.

Thomas Benjamin Karasic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.